An announcement from AK Medical Holdings Ltd. ( (HK:1789) ) is now available.
AK Medical Holdings Ltd. reported a substantial increase in its financial performance for the year ended December 31, 2024, with revenue rising by 23.1% and net profit increasing by 50.4% compared to the previous year. This growth is attributed to heightened demand for surgical products driven by the volume-based procurement policy and successful market expansion efforts, including increased overseas surgeries. The company has also recommended a final dividend payment of HK$7.2 cents per share, reflecting its robust financial health and commitment to shareholder returns.
More about AK Medical Holdings Ltd.
AK Medical Holdings Ltd. operates in the medical industry, focusing on surgical products with a particular emphasis on digital orthopedics solutions. The company is actively expanding its market presence both domestically and internationally, leveraging policies like volume-based procurement to enhance product coverage in hospitals.
YTD Price Performance: 10.31%
Average Trading Volume: 5,411,752
Technical Sentiment Signal: Hold
Current Market Cap: HK$6B
See more data about 1789 stock on TipRanks’ Stock Analysis page.